Your browser doesn't support javascript.
loading
Willingness to provide a hair sample for drug testing: results from an anonymous multi-city intercept survey.
Won, Nae Y; Jabot, Brittney; Wang, Anna; Palamar, Joseph J; Cottler, Linda B.
Afiliação
  • Won NY; Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA.
  • Jabot B; Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA.
  • Wang A; Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA.
  • Palamar JJ; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
  • Cottler LB; Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA.
Am J Drug Alcohol Abuse ; 50(2): 261-268, 2024 Mar 03.
Article em En | MEDLINE | ID: mdl-38547406
ABSTRACT

Background:

Hair provision for drug testing can provide secondary measurement to complement self-reported drug use data, thereby providing a more accurate representation of an individual's drug use. Understanding factors associated with hair provision offers valuable insights into recruitment methods.

Objective:

To identify demographic and drug-related correlates of providing hair samples in a multi-site venue-intercept study.

Methods:

We utilized venue-intercept sampling for our Rapid Street Reporting study across 12 US cities between January and November 2022. Participants reported past 12-month drug use and were asked if they would provide a hair sample. We conducted multivariable (generalized linear model with logit link) analyses on demographics and drug use characteristics correlated to hair provision for drug testing.

Results:

Among 3,045 participants, 55.8% were male, 13.6% provided hair samples. Compared to males, those identifying as "other gender" had higher odds of hair collection (adjusted odds ratio = 2.24, 95% confidence interval 1.28-3.80). Participants identifying as Black (aOR = 0.32, CI 0.23-0.45) or "other race" (aOR = 0.50, 95% CI 0.29-0.80) had lower odds of providing hair than those identifying as White. All levels of reported drug use - one drug (aOR=1.50, 95% CI 1.15-1.96), two-three drugs (aOR=1.51, 95% CI 1.11-2.05), four or more (aOR = 2.13, 95% CI 1.50-3.01) - had higher odds of providing hair samples than those reporting no drug use. Similar associations applied to reporting cannabis use with or without another drug (aOR = 1.52-1.81, 95% CI 1.15-2.38).

Conclusion:

Differential hair provision based on participant sex, race/ethnicity, and drug use may introduce biases in drug testing, limiting generalizability to individuals from minority backgrounds.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Detecção do Abuso de Substâncias / Transtornos Relacionados ao Uso de Substâncias / Cabelo Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Am J Drug Alcohol Abuse Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Detecção do Abuso de Substâncias / Transtornos Relacionados ao Uso de Substâncias / Cabelo Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Am J Drug Alcohol Abuse Ano de publicação: 2024 Tipo de documento: Article